Document Detail


Alternatives to lung transplantation: treatment of pulmonary arterial hypertension.
MedLine Citation:
PMID:  21511098     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of targeted therapies for pulmonary arterial hypertension currently based on prostaglandin, nitric oxide, and endothelin pathways has resulted in major advances in the treatment of patients with pulmonary arterial hypertension. This article reviews the current evidence that supports both the use of mono- and combination therapy. The article also considers the role of atrial septostomy in the treatment of pulmonary arterial hypertension, particularly as a bridge to transplantation. Finally, the article provides a review of the role and outcomes of pulmonary thromboendartertectomy for patients with chronic thromboembolic pulmonary hypertension.
Authors:
Paul A Corris
Related Documents :
15647888 - Is surgical clipping becoming underused?
20885918 - Ruptured intracranial mycotic aneurysm in infective endocarditis: a natural history.
21125458 - Treatment of post-hemorrhagic cerebral vasospasm: role of endovascular therapy.
17171048 - Brainstem origins of the n18 component of the somatosensory evoked response.
22329828 - Carotid-jugular fistula diagnosed by transesophageal echocardiography.
25390608 - Branch retinal artery occlusion after periocular dermal filler injection.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinics in chest medicine     Volume:  32     ISSN:  1557-8216     ISO Abbreviation:  Clin. Chest Med.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-04-22     Completed Date:  2011-08-15     Revised Date:  2011-12-06    
Medline Journal Info:
Nlm Unique ID:  7907612     Medline TA:  Clin Chest Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  399-410     Citation Subset:  IM    
Copyright Information:
Copyright © 2011. Published by Elsevier Inc.
Affiliation:
Institute of Cellular Medicine, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust, NE77DN, UK. Paul.corris@ncl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use
Atrial Septum / surgery
Endarterectomy
Epoprostenol / analogs & derivatives,  therapeutic use
Humans
Hypertension, Pulmonary* / drug therapy,  mortality,  surgery
Phosphodiesterase 5 Inhibitors / therapeutic use
Prognosis
Receptors, Endothelin / antagonists & inhibitors
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Phosphodiesterase 5 Inhibitors; 0/Receptors, Endothelin; 35121-78-9/Epoprostenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alternatives to lung transplantation: lung volume reduction for COPD.
Next Document:  Central corneal thickness in a healthy Spanish population.